VIMIAN GROUP AB (0V0 F) stock market data APIs
€3.5165
0(0%)
as of July 1, 2025
Try our APIs with
free plan!
VIMIAN GROUP AB Financial Data Overview
Price chart is built with
Anychart
Vimian Group AB (publ) engages in the animal health business worldwide. It operates through Specialty Pharma, MedTech, Diagnostics, and Veterinary Services segments. The company offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals under the Nextmune brand name; and molecular and immunodiagnostic solutions that are used by laboratories for veterinary specific applications with a focus on livestock and companion animal health markets under the Indical Bioscience brand name. It also provides procurement and tech-driven operations, such as online marketing, and education and HR, as well as a community for veterinary clinics through a membership-based platform under the VetFamily brand name; and orthopedic implants for veterinarians and universities under the Movora brand name. Vimian Group AB (publ) was incorporated in 2020 and is headquartered in Stockholm, Sweden.
Prev. Close
3.5165
Open
3.5165
High
3.5165
Low
3.5165
52 wk Range
2.745-4.155
Market Cap
1 908 M
P/E Ratio
88.4
Shares Outstanding
518 M
Revenue
391 M
Beta
1.561
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get VIMIAN GROUP AB data using free add-ons & libraries
Get VIMIAN GROUP AB Fundamental Data
VIMIAN GROUP AB Fundamental data includes:
- Net Revenue: 391 M
- EBITDA: 82 100 K
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
VIMIAN GROUP AB News
New
European Growth Stocks With Strong Insider Ownership
Amidst a backdrop of geopolitical tensions and economic uncertainties, European markets have faced recent declines, with indices such as the STOXX Europe 600 and Germany's DAX reflecting these challen...
European Stocks Possibly Trading Below Estimated Value In June 2025
As European markets navigate a landscape of easing inflation and potential interest rate cuts by the European Central Bank, investor focus is increasingly turning towards stocks that might be trading ...
3 European Stocks Estimated To Be Up To 33.6% Below Intrinsic Value
As trade tensions show signs of easing, European markets have experienced a positive uptick, with the STOXX Europe 600 Index climbing 2.77% and major indices like Germany's DAX and France's CAC 40 als...
European Growth Stocks With Insider Ownership And Up To 14% Revenue Growth
In the midst of escalating trade tensions and market volatility, European indices have experienced fluctuations, with the pan-European STOXX Europe 600 Index ending lower as central banks heighten the...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
